Advisory Board
Sitaramaraju Yarramraju PhD, Founder and Chief Executive Officer of Avant Santé Research Center SA de CV, Mexico. He has experience on regulatory & clinical development strategy and operations for innovator and semi-innovator drugs. His firm is actively involved in trials for COVID-19 infected patients and is a significant investor in our trials.
Dr. Thomas Klein, Chief Executive Officer and Business Director of the Research Center Pharmaceutical Engineering GmbH (RCPE), Europe’s leading research center for pharmaceutical process and product design. Dr. Klein Co-Founded RCPE in 2008. He is presently Chairman of the Wertheim Privatstiftung (Wertheim Foundation) and he is acting as a Business Mentor for several Start Up companies in the field of Life-Science solutions.
Arun J. Sanyal M.B.B.S. MD, Professor, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, He is a senior faculty member in various departments within Virginia Commonwealth University, holding professorships in research and teaching, and had been chairman of the departments. was recently appointed as Interim-Chair of the Division of Gastroenterology, Hepatology and Nutrition at Virginia Commonwealth University. Dr. Sanyal is a Professor of Medicine, Physiology and Molecular Pathology. Dr. Sanyal also serves as Chair of the NIH NASH Clinical Research Network, the NIMBLE consortium and the Liver Forum for NASH and fibrosis. His research interests include all aspects of NAFLD and NASH as well as complications of cirrhosis and end stage liver disease His scientific accomplishment includes over 234 publications in International Journals, 3 book, 35 book chapters, 224 abstracts reviewed for publication, 176 invited reviews and editorials in peer-reviewed journals, and 357 invited lectures.
Prof. Dr. Johannes Khinast PhD is Professor at TUGraz (Austria) and the head of the Institute for Process and Particle Engineering and Dr. Khinast is the author of more than 300 peer reviewed papers and the Chief Executive Officer and Scientific Director, The Research Center Pharmaceutical Engineering GmbH (RCPE), Europe's leading research center for pharmaceutical process and product design. Dr. Khinast Co-Founded RCPE together with Dr. Thomas Klein in 2008.
Tomas Pulido MD, Professor, Deputy director of Clinical Research, Ignacio Chavez National Heart Institute, Mexico City and is also an Associate Professor of Medicine at the National Autonomous University of Mexico (UNAM). He currently also as a Respiratory Medicine consultant at the Medica Sur Clinical Foundation (Private Institution). As authored over 150 book chapters and peer reviewed papers that include a primary focus on Pulmonary Arterial Hypertension.
Harm Jan Bogaard PhD MD, Professor of Experimental Pulmonary Medicine, Pulmonologist. Department of Pulmonary Medicine, University Medical Centers, Amsterdam. Dr. Bogaard is a very well accomplished scientist and practicing doctor with over 192 publications in International Journals, 81 invited lectures, 6 Oral abstract presentations at international meetings, and has contributed to 13 books in the area of Pulmonary Arterial Hypertension, Lung Disease and Right Heart Failure.
​
Sang-Do Lee PhD, President, Asan Medical Center (2017-2021), President, Korean Academy of Tuberculosis and Lung Disease (2022), Professor of Medicine, University of Ulsan College of Medicine, Department of Pulmonary and Critical Care Medicine Director, Clinical Research Center for Chronic Obstructive Airway Diseases
​
Basar Bilgicer, PhD - Professor, Chemical and Biomolecular Engineering, University of Notre Dame. Ph.D. in Chemistry, Tufts University; Postdoctoral Fellow, Harvard University.
The Peanut Allergy Advisory Board, separate from the Artin Bioscience Inc. Board above, includes Thomas Klein, D. Johannes Khinast, Basar Bilgicer and:
Mark Kaplan, PhD - Professor Kaplan is the Chair of the Department of Microbiology Immunology at the Indiana University School of Medicine, and he is also the Nicole Brown Professor of Immunology. He received an Honours B.Sc. from the University of Windsor in 1987 (Biology) and a PhD. from Wayne State University in 1992 (Immunology and Microbiology). He did postdoctoral work at the University of Texas Southwestern Medical Center and at the Harvard University School of Public Health. Conducted confirmatory peanut allergy preclinical trials.